1. Home
  2. MPX vs PLYX Comparison

MPX vs PLYX Comparison

Compare MPX & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marine Products Corporation

MPX

Marine Products Corporation

HOLD

Current Price

$7.44

Market Cap

319.2M

Sector

Industrials

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$5.45

Market Cap

262.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MPX
PLYX
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.2M
262.3M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
MPX
PLYX
Price
$7.44
$5.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
33.3K
2.0M
Earning Date
04-23-2026
01-01-0001
Dividend Yield
7.85%
N/A
EPS Growth
N/A
N/A
EPS
0.32
N/A
Revenue
$244,419,000.00
N/A
Revenue This Year
$13.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.13
N/A
Revenue Growth
3.32
N/A
52 Week Low
$6.83
$2.20
52 Week High
$10.08
$8.15

Technical Indicators

Market Signals
Indicator
MPX
PLYX
Relative Strength Index (RSI) 45.80 52.51
Support Level $6.83 $2.37
Resistance Level $9.16 $7.43
Average True Range (ATR) 0.17 1.11
MACD 0.07 0.22
Stochastic Oscillator 78.38 59.79

Price Performance

Historical Comparison
MPX
PLYX

About MPX Marine Products Corporation

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: